US2013066391A1PendingUtilityA1

Techniques for selecting signal delivery sites and other parameters for treating depression and other neurological disorders, and associated systems and methods

Assignee: HULVERSHORN JUSTINPriority: Aug 5, 2008Filed: Sep 7, 2012Published: Mar 14, 2013
Est. expiryAug 5, 2028(~2 yrs left)· nominal 20-yr term from priority
A61B 5/055A61B 6/501A61B 5/4064A61N 2/004A61N 1/36082A61N 1/0531
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure is directed generally to techniques for selecting signal delivery sites and other signal delivery parameters for treating depression and other neurological disorders. A method in accordance with a particular embodiment includes obtaining first imaging information corresponding to a first region of a patient's brain, the first imaging information being based at least in part on functional characteristics of the first region. The method includes obtaining second imaging information corresponding to a second region of the patient's brain, the second region being a subset of the first region, the second imaging information being based at least in part on functional or structural characteristics of the second region. A target neural population is selected based in part on the second imaging information. The method still further includes applying an electromagnetic signal to the target neural population to improve a patient function.

Claims

exact text as granted — not AI-modified
1 - 25 . (canceled) 
     
     
         26 . A method for treating a patient, comprising:
 identifying a patient as having depression;   identifying a baseline level of the patient's motor cortex excitability;   for multiple areas of the patient's DLPFC:
 applying stimulation to the patient's DLPFC using rTMS techniques; 
 after applying stimulation to the patient's DLPFC, identifying a change in the patient's motor cortex excitability using paired-pulse TMS stimulation; 
   based at least in part on identified changes in the patient's motor cortex excitability for the multiple areas of the patient's DLPFC, selecting a signal delivery site;   implanting at least one electrode proximate to the signal delivery site, within a cranial cavity of the patient's skull and outside a cortical surface of the patient's brain; and   reducing or eliminating patient depression by preferentially directing electrical signals from the at least one electrode to the signal delivery site.   
     
     
         27 . The method of  claim 26  wherein selecting a signal delivery site includes selecting the signal delivery site to be at an area of the DLPFC that has a greater effect on motor cortex excitability than other areas of the DLPFC. 
     
     
         28 . The method of  claim 26 , wherein applying stimulation to the patient's DLPFC includes applying stimulation for a period of about 20 minutes. 
     
     
         29 . The method of  claim 26 , further comprising repeating the process of identifying a change in the patient's motor cortex excitability and the process of selecting a signal delivery site during the course of the patient's therapy to account for patient adaptation to the electrical signals.

Join the waitlist — get patent alerts

Track US2013066391A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.